IDDM2/insulin VNTR modifies risk conferred by IDDM1/HLA for development of Type 1 diabetes and associated autoimmunity.
about
Insulin protects islets from apoptosis via Pdx1 and specific changes in the human islet proteomePrimary prevention of beta-cell autoimmunity and type 1 diabetes - The Global Platform for the Prevention of Autoimmune Diabetes (GPPAD) perspectivesA functional framework for interpretation of genetic associations in T1DRole of Type 1 Diabetes-Associated SNPs on Risk of Autoantibody Positivity in the TEDDY Study.Environmental factors and primary prevention in type 1 diabetes.Thymus-specific deletion of insulin induces autoimmune diabetes.Primary dietary intervention study to reduce the risk of islet autoimmunity in children at increased risk for type 1 diabetes: the BABYDIET studyAge of islet autoantibody appearance and mean levels of insulin, but not GAD or IA-2 autoantibodies, predict age of diagnosis of type 1 diabetes: diabetes autoimmunity study in the young.Assessment of type 1 diabetes risk conferred by HLA-DRB1, INS-VNTR and PTPN22 genes using the Bayesian network approach.Proinsulin is encoded by an RNA splice variant in human blood myeloid cells.Predictors of Progression From the Appearance of Islet Autoantibodies to Early Childhood Diabetes: The Environmental Determinants of Diabetes in the Young (TEDDY).Effects of non-HLA gene polymorphisms on development of islet autoimmunity and type 1 diabetes in a population with high-risk HLA-DR,DQ genotypes.Etiopathogenesis of insulin autoimmunity.The stages of type 1A diabetes.Do non-HLA genes influence development of persistent islet autoimmunity and type 1 diabetes in children with high-risk HLA-DR,DQ genotypes?Patterns of β-cell autoantibody appearance and genetic associations during the first years of life.Staging presymptomatic type 1 diabetes: a scientific statement of JDRF, the Endocrine Society, and the American Diabetes Association.Mature high-affinity immune responses to (pro)insulin anticipate the autoimmune cascade that leads to type 1 diabetes.Insulin gene VNTR genotype associates with frequency and phenotype of the autoimmune response to proinsulin.Activation of islet autoreactive naïve T cells in infants is influenced by homeostatic mechanisms and antigen-presenting capacity.Improving prediction of type 1 diabetes by testing non-HLA genetic variants in addition to HLA markers.Risk genes and autoantibodies in Egyptian children with type 1 diabetes - low frequency of autoantibodies in carriers of the HLA-DRB1*04:05-DQA1*03-DQB1*02 risk haplotype.Associations of polymorphisms in non-HLA loci with autoantibodies at the diagnosis of type 1 diabetes: INS and IKZF4 associate with insulin autoantibodies.The association of variable number of tandem repeats of the insulin gene with susceptibility to type 1 diabetes among Korean subjects.Genetics of type 1 diabetes
P2860
Q24677071-E703DB92-282E-4513-B087-C87113CE5A29Q26748984-B6D9C2C7-84AF-4FB3-A50B-DF286FFB7A4EQ27001083-81CD8A87-A10E-4D21-8486-1B9764586533Q30301275-DDE97FCD-832B-4FA6-B064-5E58E2F961C3Q34477792-B9BA7386-5B84-49AF-8C43-843DF6230938Q34610806-8260064C-C68A-42E0-BDC5-696FF673EB4AQ35043312-22F860A3-4F20-4C70-B6C2-0D1231D195B7Q35043330-C1BCA7CC-63CD-48DE-B17A-835EDA22B857Q35048490-B170641E-736A-4568-A466-E84CD6445269Q35102415-1B48EDC3-BA39-408B-82D6-1F591916503BQ35531906-6CDD1DB3-1ACA-47F4-B00C-B19312C760F4Q35766919-9C6C8B69-61C7-4E65-A73E-E8693895CC9CQ35910119-529184B2-C80D-46AC-900E-E3C3D979BDEDQ36242813-7D6FCF34-B8FC-4B15-8DAA-E112A8DE8C06Q37141752-D270234D-4685-4445-ABD8-EC4C041D6512Q37193363-ED7CD098-DE5A-4214-8DC4-7242E3E45F5BQ37659402-B4DB177C-237F-4F2C-9C22-B6567CE4BA42Q39676482-070C6A92-DA4F-49EF-B256-9660B7908B48Q39796792-03794247-B22B-437E-BF6A-CF8936DFC950Q40946283-A02F342E-B8B9-4833-B2B9-3040AEE261FFQ41810549-0AD78145-8566-4022-B910-9A6F64949638Q46154464-DF69BE00-6D02-4FBC-8A2C-628B11649D21Q50950195-ED1A2334-CC73-48F3-9464-8826196862D5Q53465553-92C826C3-2FB0-421D-8BA4-0A92B5E15AC0Q56899103-73C8E70D-8731-4C17-A299-54E4F2335161
P2860
IDDM2/insulin VNTR modifies risk conferred by IDDM1/HLA for development of Type 1 diabetes and associated autoimmunity.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
IDDM2/insulin VNTR modifies ri ...... s and associated autoimmunity.
@en
IDDM2/insulin VNTR modifies ri ...... s and associated autoimmunity.
@nl
type
label
IDDM2/insulin VNTR modifies ri ...... s and associated autoimmunity.
@en
IDDM2/insulin VNTR modifies ri ...... s and associated autoimmunity.
@nl
prefLabel
IDDM2/insulin VNTR modifies ri ...... s and associated autoimmunity.
@en
IDDM2/insulin VNTR modifies ri ...... s and associated autoimmunity.
@nl
P2093
P2860
P1433
P1476
IDDM2/insulin VNTR modifies ri ...... s and associated autoimmunity.
@en
P2093
A-G Ziegler
P2860
P2888
P304
P356
10.1007/S00125-003-1082-Z
P577
2003-05-16T00:00:00Z